LivaNova PLC (NASDAQ:LIVN) traded down 2.5% during mid-day trading on Friday . The company traded as low as $61.02 and last traded at $61.02, with a volume of 539,309 shares. The stock had previously closed at $62.56.

Separately, Piper Jaffray Cos. reissued an “overweight” rating and set a $70.00 price target (up from $59.00) on shares of LivaNova PLC in a research note on Friday. Five research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $69.00.

The firm’s market capitalization is $2.98 billion. The stock has a 50 day moving average price of $51.03 and a 200 day moving average price of $52.74.

In other LivaNova PLC news, Director Hugh M. Morrison sold 3,600 shares of the business’s stock in a transaction that occurred on Thursday, May 19th. The stock was sold at an average price of $48.00, for a total transaction of $172,800.00. Following the completion of the sale, the director now directly owns 5,215 shares in the company, valued at approximately $250,320. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Daniel Jeffrey Moore sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 24th. The stock was sold at an average price of $50.07, for a total value of $50,070.00. Following the sale, the director now owns 64,137 shares of the company’s stock, valued at $3,211,339.59. The disclosure for this sale can be found here.

Other large investors have recently bought and sold shares of the company. First Trust Advisors LP purchased a new stake in LivaNova PLC during the fourth quarter valued at approximately $1,134,000. Comerica Bank purchased a new stake in LivaNova PLC during the fourth quarter valued at approximately $1,542,000. New York State Common Retirement Fund purchased a new stake in LivaNova PLC during the fourth quarter valued at approximately $2,404,000. Nicholas Co. Inc. WI purchased a new stake in LivaNova PLC during the fourth quarter valued at approximately $4,034,000. Finally, KBC Group NV purchased a new stake in LivaNova PLC during the fourth quarter valued at approximately $4,610,000.

LivaNova PLC is a United Kingdom-based medical technology company. The Company focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company operates under three business units: Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. The Company provides solutions for patients, healthcare professionals and healthcare systems.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.